Alpha-antitrypsin topical - Arriva-ProMetic

Drug Profile

Alpha-antitrypsin topical - Arriva-ProMetic

Alternative Names: AAT topical - Arriva-ProMetic; Alpha-1 antitrypsin - Arriva-ProMetic; AP-102 gel; Dermolastin; rAAT gel; rAAT topical - Arriva-ProMetic

Latest Information Update: 31 Oct 2006

Price : $50

At a glance

  • Originator Arriva-ProMetic
  • Class Acute-phase proteins; Alpha globulins; Blood proteins; Secretory proteinase inhibitory proteins; Serpins
  • Mechanism of Action Serine endopeptidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Atopic dermatitis; Dermatitis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 31 Oct 2006 No development reported - Phase-II for Atopic dermatitis in Canada (Topical)
  • 31 Oct 2006 No development reported - Phase-II for Dermatitis in United Kingdom (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top